Latest Shareholder Approvals News

Page 4 of 388
BCAL Diagnostics, an 18.46% shareholder of Genetic Signatures, has asked the Takeovers Panel to intervene over the proposed merger with Microba Life Sciences. The application alleges the deal structure and shareholder process lack adequate protections, although no Panel has yet been appointed and no decision has been made.
Ada Torres
Ada Torres
13 Nov 2026
Genetic Signatures’ proposed Microba merger faces a formal challenge from 18.46% shareholder BCAL Diagnostics, which alleges the process lacks adequate protections and information for GSS investors. The Takeovers Panel has not yet appointed a sitting Panel or decided whether to open proceedings.
Ada Torres
Ada Torres
13 Nov 2026
Talonx Resources has launched a non-underwritten share purchase plan targeting up to A$1 million from eligible Australian and New Zealand shareholders at A$0.005 a share. The funds are earmarked for expanded copper and base-metals exploration in Botswana, further gold drilling in Western Australia and working capital.
Maxwell Dee
Maxwell Dee
13 Nov 2026
OpenLearning has secured a $500,000 investment from Philippine conglomerate World Citi Group, lifting commitments to its capital raising to approximately $1.48 million. The deal adds a potential technology partnership to a funding effort backed by record SaaS growth, but the larger entitlement offer still depends on shareholder participation.
Sophie Babbage
Sophie Babbage
13 Nov 2026
Wide Open Agriculture has secured a $1 million placement to fund manufacturing trials, commercial development and working capital as it targets a return to lupin ingredient production in Q2 2027. The raise strengthens its cash position, but production still depends on selecting a partner and completing technical validation.
Victor Sage
Victor Sage
13 Nov 2026
Xenora Minerals is acquiring the Errolls Gold and Limestone Well projects in Western Australia, creating a 115-square-kilometre exploration package beside Solstice Minerals’ Nanadie copper-gold discovery. The deal comes with a A$5 million placement, a new executive chair and an ambitious drilling program, but completion and exploration success remain unproven.
Maxwell Dee
Maxwell Dee
13 Nov 2026
Big River Industries has agreed to a $1.62-a-share cash scheme with CTL, valuing its equity at approximately $156 million and securing support from shareholders controlling 59.5% of the register. The deal remains conditional on ACCC, Court, independent expert and shareholder approvals, with completion targeted for early 2027.
Victor Sage
Victor Sage
13 Nov 2026
RBR Group has secured A$600,000 through a placement and reworked all A$1.25 million of its convertible notes, giving it near-term funding to deliver its first post-restart Rovuma LNG contract. The financing strengthens the bridge to execution, but leaves shareholders facing further dilution and the company still dependent on future awards.
Victor Sage
Victor Sage
13 Nov 2026
Cynata Therapeutics has lifted its proposed shareholder-approved placement to approximately $750,000, taking potential proceeds from its two-stage capital raising to about $1.663 million before costs. The biotech says key clinical and termination costs have been paid, while its externally funded kidney transplant trial remains in follow-up.
Ada Torres
Ada Torres
13 Nov 2026
Alcidion has entered FY27 with record contracted revenue, a debt-free balance sheet and reaffirmed guidance for revenue and underlying EBITDA to exceed FY26. Shareholders also approved a 10-for-1 share consolidation as the healthcare software company weighs buy-backs, acquisitions and further platform investment.
Victor Sage
Victor Sage
12 Nov 2026
Bridge SaaS ended September with just A$31,000 in cash after a A$1.455 million operating outflow, leaving an estimated 0.02 quarters of funding. The company says its solvency depends on lower costs and timely NDIS receipts, while a potential A$2 million placement remains uncommitted.
Victor Sage
Victor Sage
12 Nov 2026
Auric Mining has secured A$17 million from institutional and existing investors to expand its gold resource base, fund drilling and progress Burbanks. A further A$3 million Share Purchase Plan remains subject to an ASX waiver, while the company says full project development will require additional funding.
Maxwell Dee
Maxwell Dee
12 Nov 2026

Browse the archive

Full archive